<?xml version="1.0" encoding="UTF-8"?>
<p>However, TMZ‐based chemotherapy for EPNEC is not sufficiently effective as an urgent treatment. In a previous study, TMZ monotherapy or TMZ in combination with capecitabine and bevacizumab for EPNEC showed a response rate of 0%–57% and a PFS of 2.4‐8.4 months.
 <xref rid="cas14811-bib-0015" ref-type="ref">
  <sup>15</sup>
 </xref>, 
 <xref rid="cas14811-bib-0016" ref-type="ref">
  <sup>16</sup>
 </xref>, 
 <xref rid="cas14811-bib-0022" ref-type="ref">
  <sup>22</sup>
 </xref>
</p>
